PDS Biotechnology develops immunotherapies that aim to treat cancer and to prevent infectious diseases. It last closed at $0.78 on Nov 20, down 3.70% on the day. The next earnings report for PDSB is expected around Mon, Mar 29, 2027. For the quarter ended Sep 2026, PDSB reported EPS of -$0.11. Over its last 8 reports the stock moved an average of 6.9% the session after earnings.
AI Auto Pilots
Is PDSB in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold PDSB.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on PDSBStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
PDSB · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend, nearing oversold
The stock is 45% below its 20 day and 34% below its 50 day average. It is 8% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 38), near oversold. The nearest support is the Pivot S1 at $0.75, and the nearest resistance the 100 day average at $0.78.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityHigh, 20.6%/day
Key levels
$1.7952 week high+129.5%
$1.1320 day average+44.9%
$1.0450 day average+33.3%
$0.84200 day average+7.7%
$0.82Pivot R1+5.1%
$0.80Pivot+2.6%
$0.80Swing high (Aug 10)+2.6%
$0.78100 day average+0.0%
$0.78Last close
$0.75Pivot S1−3.8%
$0.75Swing low (Nov 13)−3.8%
$0.2052 week low−74.4%
Indicators
RSI (14)
38.12
Weak, oversold below 30
Neutral
MACD
-0.08
Below its signal line
Bearish
Stochastic
5.0
Near the bottom of its range
Oversold
ADX (14)
28.2
Trending down
Williams %R
-96.5
Oversold below −80, overbought above −20
Oversold
CCI (20)
-103.6
Oversold below −100, overbought above 100
Oversold
Rate of change
−36.8%
Change over 10 sessions
Bearish
ATR (14)
$0.16
Typical daily range, 20.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Below
Moving sideways
Short trendNeutral
Long trendBearish
MomentumImproving
StretchNormal
VolatilityHigh, 43.1%/day
Key levels
$1.7952 week high+129.5%
$1.1320 day average+44.9%
$1.0450 day average+33.3%
$0.84200 day average+7.7%
$0.82Pivot R1+5.1%
$0.80Pivot+2.6%
$0.80Swing high (Aug 10)+2.6%
$0.78100 day average+0.0%
$0.78Last close
$0.75Pivot S1−3.8%
$0.75Swing low (Nov 13)−3.8%
$0.2052 week low−74.4%
Indicators
RSI (14)
47.92
Middle of its range
Neutral
MACD
0.06
Above its signal line
Bullish
Stochastic
48.0
Middle of its range
Neutral
ADX (14)
30.4
Trending up
Williams %R
-63.5
Oversold below −80, overbought above −20
Neutral
CCI (20)
15.2
Oversold below −100, overbought above 100
Neutral
Rate of change
+163.6%
Change over 10 sessions
Bullish
ATR (14)
$0.34
Typical daily range, 43.1% of price
MA 10Below
MA 20Above
MA 50Below
MA 100Below
MA 200Below
What happened before, for PDSB
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how PDSB did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow PDSB usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for PDSBHow many large options trades hit PDSB, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in PDSB in the last 90 days.
From SEC Form 4 filings by PDSB's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether PDSB is in one of them and how their past PDSB trades turned out.
PDS Biotechnology is a clinical stage immunotherapy company based in Princeton, New Jersey. It is developing cancer treatments built on its Versamune platform, including a combination with an interleukin 12 antibody drug conjugate, and an Infectimune T cell activator for preventive vaccines against infectious agents. The Versamune platform is a lipid nanoparticle designed to stimulate the immune system's killer and helper T cells. Its investigational products are aimed at patients with cancer and at preventive vaccines for infectious diseases.